Abstract:Objective To study dendritic cells(DC)precursors that were mobilized into the pe- ripheral blood by injection of macrophage inflammation protein-1α(MIP-1α)and the anti-tumor effects induced by MIP-1αmobilized DC vaccine expressing tumor antigen in vivo.Methods 615 mice were in- jected with MIP-1αvia the tail vein.B220~-CD11c~+cells were sorted from the peripheral blood mononu- clear cells(MNCs)by FACS.The quantitive change of B220~-CD11c~+cells were compared among MNCs.Freshly isolated B220~-CD11c~+cells and B220~-CD11c~+cells cultured with mouse granulocyte- macrophage colony-stimulating factor(mGM-CSF),interleukin 4(IL-4),and mouse tumor necrosis factor-α(mTNF-α)were analyzed by phenotype analysis,and mixed lymphocyte reaction(MLR).For adenovi- ral(Ad)-mediated gene transduetion,cultured B220~-CD11c~+cells were incubated with Ad-melanoma antigen gene-3.B220~-CD11c~+cells pulsed mouse forestomach carcinoma cells(MFC)tumor lysate was used as control.To establish the solid tumor model,groups of 615 mice were injected with MFC cells sub- cutaneously in the abodminal wall.DC vaccines were immunized after the challenge of MFC cells,then the tumor size and the survival of mice which could detect the anti-tumor effects of DC vaccines were ob- served.Results B220~-CD11c~+cells were increased in the circulation 8 h after MIP-1αinjection, then gradually reached a peak level 48 h after injection,accounting for(13.68±0.95)% among MNCs. Freshly isolated B220~-CD11c~+cells did not show the characters of mature DC,while cultured B220~- CD11c~+cells were phenotyically identical to typical DC and gained the capacity to stimulate allogeneie T cells.These MIP-1αmobilized DCs were transduced with Ad-MAGE-3,which were prepared for DC vac- cines expressing tumor antigen.Five days after the challenge of MFC cells,mice were subsequently injected with DC vaccines.The.tumor size in the experimental group was much smaller than that in the control groups 27 days after the challenge.Kaplan-Meier survival curves revealed that the survival of the mice in the experimental group was much longer than that in the control groups(P<0.01).Conclusion B220~- CD11c~+DC precursors were rapidly accumulated in the peripheral blood after injection of MIP-1αin mice,which could further differentiate into mature DCs.These MIP-1αmobilized DCs,when transduced with MAGE-3 gene,could generate therapeutic anti-tumor effects on MFC cells loading mice in vivo.The efficiency of anti-tumor immunity induced by MIP-1αmobilized DCs expressing tumor antigen were much more potent than MIP-1αmobilized DCs pulsed MFC cells tumor lysate.

Anti-bladder Cancer Effect in Vitro of Novel Dendritic Cell Vaccine Modified with B7-H1 Short Hairpin RNA and Pulsed with Tumor Antigen

Silencing B7-H1 Enhances the Anti-Tumor Effect of Bladder Cancer Antigen-Loaded Dendritic Cell Vaccine in Vitro

Anti-tumor Immunity with Dendritic Cells ( DC) Vaccine Modified by IL-18

Anti-tumor effect of dendritic cell vaccines transfected with total RNA of A549 cells in vitro

Making and Evaluation of Tumor Vaccine from Murine Bladder Tumor Cells Transfected with B7-1 Gene

The anti-tumor immune response of specific cytotoxic T lymphocytes induced by breast cancer stem cells RNA-DCs vaccine

Inhibitory effects of dendritic cell (DC) vaccine loading antigen with irradiated apoptotic MB49 tumor cells against bladder cancer cells in mice

Experimental study on enhancement of immune function of dendritic cells from peripheral blood of patients with bladder cancer by blocking the B7-H1 pathway

Enhanced anti-tumor immunity of vaccine combined with anti-PD-1 antibody in a murine bladder cancer model

Inhibitory Effects of a Dendritic Cell Vaccine Loaded with Radiation-Induced Apoptotic Tumor Cells on Tumor Cell Antigens in Mouse Bladder Cancer.

Experimental Study of Treatment ofIntracranial G422 Glioblastoma with Bone Marrow-derived Dendritic Cells Vaccine

Antitumor therapeutic effect induced by intestine- carcinoma cells vaccine expressing membrane- bound heat shock protein 70

Basic Research of Integrative Therapy for Bladder Cancer

Anti-gastric carcinoma efficacy of gene modified dendritic cell vaccine recruited by macrophage inflammation protein-1

Experimental Study of Treatment of Prostate Cancer with Murine Dendritic Cells Pulsed with Tumor Cell RNA

Antitumor Effect of Lung Cancer Vaccine with Umbilical Blood Dendritic Cells in Reconstituted Scid Mice

Reduction of Major Histocompatibility Complex Class I Expression on Bladder Carcinoma Following Tumor Antigen‐pulsed Dendritic Cell Vaccine: Implications for Immunoresistance in Therapy

Enhanced Therapeutic Efficacy Of Tumor Rna-Pulsed Dendritic Cells After Genetic Modification With Lymphotactin

Primary Study of B7-1 Modified Tumor Vaccine Combined with Allicin for Bladder Cancer

Antitumor Effects of Vaccine Consisting of Dendritic Cells Pulsed with Tumor RNA from Gastric Cancer

Oct4 and Hypoxia Dual-Regulated Oncolytic Adenovirus Armed with shRNA-Targeting Dendritic Cell Immunoreceptor Exerts Potent Antitumor Activity against Bladder Cancer